A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success in 2020 ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...

Full Year 2024 Conference Call & Audio Webcast BioVersys will host a conference call and webcast at 2:00 PM CET to discuss the financial results, provide an update on the company’s performance, ...

The FDA approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new ...

GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...

Me’s genetic data may be for sale after bankruptcy. AI firms may want in—but privacy fears could make it a toxic asset.

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...